Investing Ideas
/
U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers

U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies available at a discount paying at least a 2% dividend yield.

1 companies

Gilead Sciences

Market Cap: US$169.3b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

GILD

US$135.82

7.8%

19.9%